Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
3.770
+0.130 (3.57%)
At close: Mar 31, 2026, 4:00 PM EDT
3.840
+0.070 (1.86%)
After-hours: Mar 31, 2026, 6:44 PM EDT
Aardvark Therapeutics Employees
Aardvark Therapeutics had 40 employees as of December 31, 2025. The number of employees increased by 18 or 81.82% compared to the previous year.
Employees
40
Change
18
Growth
81.82%
Revenue / Employee
n/a
Profits / Employee
-$1,439,775
Market Cap
82.25M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 40 | 18 | 81.82% | 40 | 0 |
| Sep 30, 2025 | 33 | 15 | 83.33% | 33 | 0 |
| Jun 30, 2025 | 31 | 17 | 121.43% | 31 | 0 |
| Mar 31, 2025 | 26 | 12 | 85.71% | 26 | 0 |
| Dec 31, 2024 | 22 | - | - | 22 | 0 |
| Sep 30, 2024 | 18 | - | - | 17 | 1 |
| Jun 30, 2024 | 14 | - | - | 12 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Rani Therapeutics Holdings | 106 |
| Verrica Pharmaceuticals | 76 |
| PolyPid | 73 |
| Pyxis Oncology | 44 |
| Vivani Medical | 37 |
| Gain Therapeutics | 25 |
| Filana Therapeutics | 20 |
AARD News
- 8 days ago - Aardvark Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 20 days ago - Aardvark Therapeutics, Inc. Investigated by the Portnoy Law Firm - GlobeNewsWire
- 27 days ago - AARD Investors Have Opportunity to Join Aardvark Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewsWire
- 27 days ago - What's Going On With Aardvark Therapeutics Stock On Wednesday? - Benzinga
- 4 weeks ago - Why Is Aardvark Therapeutics Stock Sinking Monday? - Benzinga
- 4 weeks ago - AARD Investors Have Opportunity to Join Aardvark Therapeutics, Inc. Fraud Investigation With the Schall Law Firm - Business Wire
- 4 weeks ago - Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome - GlobeNewsWire
- 6 weeks ago - Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire